Multiple Sclerosis Clinical Trial
An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS
Summary
The purpose of this study is to determine the difference in preventing a relapse between Betaseron and Avonex. Patients with RRMS currently treated with Avonex will be randomized into 2 equal-size arms; one arm will continue on the standard dose of Avonex; one arm will be converted to Betaseron standard dose.
Full Description
This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc.is the sponsor of the trial.
Eligibility Criteria
Inclusion Criteria:
RRMS patients that are receiving treatment with Avonex 30 µg once weekly
Exclusion Criteria:
Primary Progressive or Secondary Progressive MS
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 53 Locations for this study
Tucson Arizona, 85741, United States
Berkeley California, 94705, United States
Irvine California, 92697, United States
Loma Linda California, 92354, United States
Los Angeles California, 90095, United States
Sacramento California, 95817, United States
San Jose California, 95124, United States
Walnut Creek California, 94596, United States
Walnut Creek California, 94598, United States
Wilmington Delaware, 19806, United States
Melbourne Florida, 32940, United States
Miami Florida, 33136, United States
Tampa Florida, 33606, United States
Tampa Florida, 33609, United States
Atlanta Georgia, 30309, United States
Augusta Georgia, 30912, United States
Columbus Georgia, 31909, United States
Savannah Georgia, 31405, United States
Flossmoor Illinois, 60422, United States
Springfield Illinois, 62703, United States
Fort Wayne Indiana, 46805, United States
Indianapolis Indiana, 46202, United States
Des Moines Iowa, 50314, United States
Kansas City Kansas, 66160, United States
Shreveport Louisiana, 71130, United States
Baltimore Maryland, 21201, United States
Detroit Michigan, 48201, United States
Golden Valley Minnesota, 55422, United States
Minneapolis Minnesota, 55455, United States
Rochester Minnesota, 55905, United States
Kansas City Missouri, 64108, United States
St. Louis Missouri, 63110, United States
Reno Nevada, 89509, United States
Albuquerque New Mexico, 87131, United States
Albany New York, 12208, United States
Buffalo New York, 14215, United States
Mineola New York, 11501, United States
New York New York, 10003, United States
Asheville North Carolina, 28801, United States
Winston-Salem North Carolina, 27157, United States
Dayton Ohio, 45409, United States
Oklahoma City Oklahoma, 73120, United States
Medford Oregon, 97504, United States
Philadelphia Pennsylvania, 19104, United States
Providence Rhode Island, 02905, United States
Charleston South Carolina, 29425, United States
Houston Texas, 77030, United States
Fairfax Virginia, 22031, United States
Roanoke Virginia, 24014, United States
Seattle Washington, 98101, United States
Tacoma Washington, 98405, United States
Nepean Ontario, K2G 6, Canada
Ottawa Ontario, K1H 8, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.